Krasner Alan Seth 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 12, 2019
Insider Transaction Report
Form 4
Krasner Alan Seth
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-03-08+56,250→ 56,250 totalExercise: $25.19Exp: 2029-03-07→ Common Stock (56,250 underlying)
Footnotes (1)
- [F1]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the Vesting Commencement Date of March 8, 2019.